Histone Deacetylase SIRT1 Mediates C5b-9-Induced Cell Cycle in Oligodendrocytes.
Animals
Cell Cycle
/ drug effects
Cell Differentiation
/ drug effects
Cells, Cultured
Complement Membrane Attack Complex
/ pharmacology
Myelin Sheath
/ drug effects
Oligodendroglia
/ drug effects
Phosphatidylinositol 3-Kinases
/ physiology
Protein Kinase C
/ physiology
Rats
Rats, Sprague-Dawley
Sirtuin 1
/ physiology
C5b-9
SIRT1
cell cycle
cyclin D1
oligodendrocyte
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
12
2019
accepted:
18
03
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
26
3
2021
Statut:
epublish
Résumé
Sublytic levels of C5b-9 increase the survival of oligodendrocytes (OLGs) and induce the cell cycle. We have previously observed that SIRT1 co-localizes with surviving OLGs in multiple sclerosis (MS) plaques, but it is not yet known whether SIRT1 is involved in OLGs survival after exposure to sublytic C5b-9. We have now investigated the role of SIRT1 in OLGs differentiation and the effect of sublytic levels of C5b-9 on SIRT1 and phosphorylated-SIRT1 (Ser27) expression. We also examined the downstream effects of SIRT1 by measuring histone H3 lysine 9 trimethylation (H3K9me3) and the expression of cyclin D1 as a marker of cell cycle activation. OLG progenitor cells (OPCs) purified from the brain of rat pups were differentiated
Identifiants
pubmed: 32328069
doi: 10.3389/fimmu.2020.00619
pmc: PMC7160252
doi:
Substances chimiques
Complement Membrane Attack Complex
0
Protein Kinase C
EC 2.7.11.13
Sirt1 protein, rat
EC 3.5.1.-
Sirtuin 1
EC 3.5.1.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
619Informations de copyright
Copyright © 2020 Tatomir, Rao, Boodhoo, Vlaicu, Beltrand, Anselmo, Rus and Rus.
Références
Brain Res Dev Brain Res. 2002 Nov 15;139(1):29-38
pubmed: 12414091
Circ Res. 2011 May 13;108(10):1180-9
pubmed: 21474819
J Immunol. 1999 Dec 1;163(11):6132-8
pubmed: 10570303
Front Cell Neurosci. 2013 Dec 18;7:261
pubmed: 24391542
J Immunol. 1993 Jan 1;150(1):214-24
pubmed: 8417124
Science. 2010 Nov 5;330(6005):779-82
pubmed: 21051629
J Immunol. 1996 Jun 15;156(12):4892-900
pubmed: 8648139
Nature. 2007 Nov 15;450(7168):440-4
pubmed: 18004385
J Immunol. 1990 Jul 15;145(2):623-9
pubmed: 2164064
Curr Opin Genet Dev. 2019 Apr;55:1-10
pubmed: 31103921
Int J Mol Sci. 2018 Sep 12;19(9):
pubmed: 30213051
J Immunol. 1989 Jun 15;142(12):4385-91
pubmed: 2542410
Immunopharmacology. 1997 Dec;38(1-2):177-87
pubmed: 9476129
Cold Spring Harb Perspect Biol. 2015 Aug 20;8(2):a020453
pubmed: 26492571
J Immunol. 2013 May 1;190(9):4595-607
pubmed: 23547115
Exp Mol Pathol. 2017 Apr;102(2):191-197
pubmed: 28109694
Immunol Res. 2011 Oct;51(1):45-60
pubmed: 21850539
Proteomics. 2019 Jul;19(14):e1900057
pubmed: 31216117
J Neurochem. 1996 Jan;66(1):303-12
pubmed: 8522968
Mol Cell Neurosci. 2002 Feb;19(2):250-62
pubmed: 11860277
Genes Dev. 2002 Jan 15;16(2):165-70
pubmed: 11799060
Curr Opin Neurobiol. 2017 Dec;47:73-79
pubmed: 29078110
Exp Mol Pathol. 2011 Aug;91(1):335-45
pubmed: 21540025
Brain Res. 2002 Mar 1;929(1):87-95
pubmed: 11852034
Mol Cell. 2011 Apr 22;42(2):210-23
pubmed: 21504832
J Biol Chem. 2014 Aug 29;289(35):24069-78
pubmed: 25002589
Nat Commun. 2016 Dec 19;7:13866
pubmed: 27991597
J Neuroimmunol. 2008 Oct 15;203(1):94-103
pubmed: 18692252
J Immunol. 2006 Mar 1;176(5):3173-80
pubmed: 16493077
Brain Tumor Pathol. 2015 Oct;32(4):261-7
pubmed: 26233522
FEBS Lett. 2018 Apr;592(7):1063-1078
pubmed: 29427507
Semin Cell Dev Biol. 2019 Nov;95:54-73
pubmed: 29782926
Neurosci Res. 2005 Dec;53(4):436-41
pubmed: 16198437
Biochim Biophys Acta. 2014 Sep;1843(9):1917-29
pubmed: 24768715
Neurosci Lett. 2019 Jun 21;704:116-125
pubmed: 30953735
Cell Cycle. 2008 Oct;7(19):3091-7
pubmed: 18838864
Circ Res. 2014 Jan 17;114(2):368-78
pubmed: 24436432
Front Neurol. 2012 May 24;3:84
pubmed: 22654783
Glia. 2007 Aug 1;55(10):1011-22
pubmed: 17508424
Immunol Res. 2005;31(1):37-46
pubmed: 15591621
Exp Mol Pathol. 2013 Feb;94(1):17-28
pubmed: 23000427
J Neuroimmunol. 2006 Nov;180(1-2):9-16
pubmed: 16905199
J Immunol. 2001 Aug 15;167(4):2305-11
pubmed: 11490019
Mol Cancer Res. 2013 Dec;11(12):1497-507
pubmed: 24107295
Brain. 2009 Feb;132(Pt 2):465-81
pubmed: 19208690
J Immunol. 1993 May 15;150(10):4581-90
pubmed: 7683324
J Neuroophthalmol. 2010 Dec;30(4):328-39
pubmed: 21107122
Nat Cell Biol. 2013 Jun;15(6):614-24
pubmed: 23644469
Glia. 2015 Aug;63(8):1357-75
pubmed: 25970296
Glia. 2014 May;62(5):829-39
pubmed: 24550001
Neurochem Res. 2013 Mar;38(3):601-9
pubmed: 23283697
J Huntingtons Dis. 2013;2(1):101-5
pubmed: 25063433
Glia. 1998 Feb;22(2):121-9
pubmed: 9537832
Exp Mol Pathol. 2014 Apr;96(2):139-48
pubmed: 24397908
Immunol Res. 2015 Mar;61(3):187-97
pubmed: 25281273
Neuroscience. 2014 Sep 12;276:29-47
pubmed: 24275321
Glia. 2019 Jul;67(7):1277-1295
pubmed: 30761608